Morning Breakouts

Latest KFF Health News Stories

Gilead Documents Provide Rare Glimpse Into Drug Pricing Decision Making

Morning Briefing

In other pharmaceutical news, Bayer may have five new cancer drugs on the market by 2020 and AstraZeneca targets the so-called secretome — proteins secreted by cells — in the hunt for next-generation biotech medicines. Meanwhile, the FDA is starting to scrutinize the largely unregulated lab-developed test industry.

Poll: Kentuckians Overwhelmingly Support State’s Medicaid Expansion

Morning Briefing

And Pennsylvania hits the half-million mark with Medicaid sign-ups after Gov. Tom Wolf abandoned his predecessor’s hybrid model and expanded the program when he took office. In Florida, lawmakers have little hope for the expansion.

More Hospitals Dinged By Medicare For Safety Issues Than Last Year

Morning Briefing

Of the 758 facilities penalized, more than half were also punished last year. The fines are based on the government’s assessment of the frequency of several kinds of infections, sepsis, hip fractures and other complications. In other hospital news, Kaiser Health News reports on emergency room overcrowding.

U.S. Budget Deficit Widens In November

Morning Briefing

The deficit growth was, in part, driven by an uptick in spending on Medicare and Social Security, due to the burgeoning baby boomer population, and Medicaid, as a result of the health law’s expansion of the low-income health care program.

As Pressure Mounts, Lawmakers Still Scrambling Over 9/11 Responders Bill Cost

Morning Briefing

The New York Police Department commissioner joins a chorus of lawmakers, advocates and public figures demanding Congress to continue to fully fund health care benefits for 9/11 first responders. Senate Majority Leader Mitch McConnell has promised to make it happen, but one problem remains: the price tag.

Congress Moves To OK Short-Term Spending Bill To Avert Government Shutdown

Morning Briefing

The Senate agreed to extend the deadline for action on an omnibus spending bill until Wednesday, Dec. 16. Meanwhile, as these negotiations continue, a proposal to delay the health law’s so-called Cadillac tax, which is scheduled to take effect in 2018, is among the policy provisions still very much in play.

Johnson & Johnson And Google Team Up To Build Better Surgical Robots

Morning Briefing

Verb Surgical Inc — an independent company formed by J&J and Verily Life Sciences (formerly known as Google Life Sciences) — aims to produce “disruptive” alternatives to existing robotic technology used in operating rooms.

Health Rankings Find Positive Trend Even As Sicker States Slip

Morning Briefing

Many of the sickest states have remained low on America’s Health Rankings, a scorecard which looks at access to medical care, prevention and treatment of disease, avoidable hospital use and cost, healthy lives and health equity. But some states have shown dramatic improvement.

In Case ‘Cadillac Tax’ Hits, Autoworkers Union Contracts Leave Open Possibility Of New Deductibles

Morning Briefing

New four-year labor agreements between auto makers and the United Auto Workers Union allow for a change to health insurance that would add annual deductibles on plans that could trigger the 2010 health law’s so-called Cadillac tax. And in other marketplace news, Theranos CEO Elizabeth Holmes battles to save her blood-testing startup.

Rubio Touts His Anti-Obamacare Credentials In Field Of Republicans

Morning Briefing

Sen. Marco Rubio also plans to talk about troubles at the VA while stumping in Iowa with his brother, who is a veteran. In other Republican presidential campaign news, Ben Carson offers a fuller look at his national health care plan, which, in addition to repealing the 2010 health law, would overhaul Medicare and Medicaid and introduce tax-sheltered “Health Empowerment Accounts” to help consumers save for medical costs.

Puerto Rico Fiscal Relief Bill Proposes To Tap $12B Public Health Fund

Morning Briefing

The Republican measure would help Puerto Rico avoid a bond default on Jan. 1, but to get to the $3 billion price tag, the bill would use money for research and preventive medicine programs nationwide. The bill summary says the money was as yet “unobligated” and could be “repurposed.”

Senate Panel Slams Drug Companies For Skyrocketing Prices

Morning Briefing

In the first of a series of hearings to examine the cost increases for prescription drugs that are no longer protected by patents, the Senate Special Committee on Aging blasts four pharmaceutical companies for their price spikes.